Share

Identification of new therapeutic targets in patients affected by trabectedin-resistant soft tissue sarcomas

 

Project objectives

  • identify soluble factors predictive of response to immunotherapy treatment in patients with metastatic clear cell renal cell carcinoma
  • monitor the modulation of the levels of the soluble molecules identified during immunotherapy treatment

Start and end date
July 2020 – ongoing (December 2023) approximate end date)

Project Manager
Francesco Pantano (PI)

Coordinating institution of the project
Università Campus Bio-Medico di Roma

Other institutions involved in the project
Meet-URO - Urological oncology group in Italy
2023© Università Campus Bio-Medico di Roma, Via Álvaro del Portillo, 21 - 00128 Rome, Tel. +39 06.22541.1, Fax +39 06.22541.456, VAT number: 048 020 51 005, Fiscal Code: 97087620585
QUICK LINKS
L'Università Campus Bio-Medico di Roma promotes integrated teaching and research structures, pursuing the good of the person as the main aim of its activities.
magnifiercrossmenuchevron-downchevron-leftchevron-right